Literature DB >> 1259932

Chemotaxis for human monocytes by fibrinogen-derived peptides.

D L Richardson, D S Pepper, A B Kay.   

Abstract

Chemotactic activity for human peripheral blood monocytes was generated by the action of thrombin on human fibrinogen, a reaction known to release low molecular fibrinopeptides. Supernatants prepared by incubating Contortrix venom with fibrinogen, which cleaves the B peptide, were also chemotactic, whereas no activity was present in supernatants from Arvin venom, which cleaves peptides A, AP and AY. Thus fibrinopeptide B was chemotactic for the monocyte in addition to the neutrophil, as previously reported. Monocyte chemotactic activity was also generated by the action of plasmin on human fibrinogen and shown to be associated with the D and E fragments but not with a mixture of fragments X and Y. When plasmin digestion was stopped at time intervals up to 24 h, monocyte chemotactic activity corresponded with the appearance of the D and E fragments. The monocyte chemotactic activity, contained in a 24 h digest, eluted from Sephadex G-75 at VO, corresponding to the expected position of the D and E fragments whereas neutrophil chemotactic activity eluted with molecules of molecular size of approximately 30 000 daltons. Thus fragments D and E derived from plasmin digestion of fibrinogen attract the monocyte whereas only the small uncharacterized peptides were chemotactic for the neutrophil. These different profiles of chemotactic activity for the neutrophil and the monocyte in terms of plasmin digestion products of fibrinogen may be of significance in the events leading to the accumulation of these cells in vivo during fibrin deposition.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259932     DOI: 10.1111/j.1365-2141.1976.tb00953.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  29 in total

Review 1.  Novel aspects of fibrin(ogen) fragments during inflammation.

Authors:  Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski
Journal:  Mol Med       Date:  2011-01-04       Impact factor: 6.354

2.  Ligneous conjunctivitis: biochemical evidence for hypofibrinolysis.

Authors:  M L Ramsby; P C Donshik; G S Makowski
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

3.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

6.  In vivo regulation of plasminogen function by plasma carboxypeptidase B.

Authors:  Carmen M Swaisgood; Detlef Schmitt; Dan Eaton; Edward F Plow
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  2001-10       Impact factor: 4.092

8.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

9.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 10.  Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.

Authors:  Ashley C Brown; Thomas H Barker
Journal:  Acta Biomater       Date:  2013-09-19       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.